Hide Board Information

Show Board Information

Epic Penny Picks

Board Mod: planopenny

Asst Mods: Pink

Last Post: 01/30/2024 12:22:54 PM

Board Marks: 10

Posts Today: 0

Board Views Today: 7

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	Thanks Joe, Have you been following our latest	Pink	03/28/2012 5:32:22 PM
9	I'm sure that won't last long Pink, the name Epic	11072017	03/27/2012 9:52:05 PM
8		Pink	03/27/2012 9:45:43 PM
7	Investors hangout's slowest	Pink	03/27/2012 8:38:55 PM
6	We're HERE!!	Coastalgal	02/27/2012 8:33:20 AM
5	Get Marked! -------> Here:	MrGreenPenny	02/26/2012 10:53:34 PM
4	Sure is boogieman!!!  I'm the newest board	11072017	02/20/2012 7:07:08 PM
3	Is this the same board as epicpicks on	Boogieman62	02/20/2012 6:31:20 PM
2	Test number 2. Boardmarked	MrGreenPenny	02/19/2012 8:41:13 PM
1	TEST	planopenny	02/18/2012 3:23:14 PM

Newer

Recent Articles

• Sampo plc's Recent Share Buyback Insights and Impacts
• Strategic Alliance Between Dev4All and Pharmaseed Enhances R&D
• Rémy Cointreau Reveals Availability of Financial Report Online
• Getlink SE Faces Delays in ElecLink Operations Recovery
• Shenzhen's Transformative Influence on Global Branding and Quality
• Jiangsu's Transformation: Merging Rich History with Innovation
• Hexagon Purus ASA Reports Record Q3 Growth and Future Plans
• CTP Delivers State-of-the-Art Logistics Facility to Tesco
• Galderma's Nemolizumab Shows Promising Results for Itch Relief
• Explore Tokyo Psychodemic: An Immersive Gaming Experience
• Neos Corporation Unveils Enhanced Crayon Shin-chan App for iOS
• CoinEx Charity's Starlink Initiative Transforms Connectivity
• Zai Lab Boosts Patient Access to AUGTYRO for Lung Cancer
• Recursive Teams Up with Saudi Arabia for AI-Powered TB Solutions
• Akeso's Cadonilimab and Ivonescimab Added to National Drug List
• TeamT5 Earns Prestigious Recognitions in Cybersecurity Innovation
• Innovent Biologics Adds SINTBILO and Olverembatinib to NRDL
• Genesis Lifestyle Medicine Recognized for Stellar Leadership Achievement
• Genesis Lifestyle Medicine Earns Certified Amazing Workplace Honor
• Bridging Cultures: China and Europe's River Dialogues
• The Surge in Population Health Management: A $663.75 Billion Future
• Prime Mining Releases New Technical Report on Los Reyes Project
• Investigation Announced for Symbotic Inc. Shareholders
• Monument Mining Limited Reports Positive Q1 FY 2025 Results
• Strategic Alliance Between Sumitomo and Rikkeisoft Ignites Growth
• Innovative Approaches to Combat the Fall Armyworm Crisis
• Exro Technologies Faces Potential Class Action Suit
• BioArctic's Leqembi®: A New Hope for Alzheimer's Patients
• BioArctic Partners with Eisai for Leqembi Launch in Asia
• Rakovina Therapeutics Unveils New Financial Strategy for Growth
• Nonwoven Filtration Market Expected to Hit $8.4 Billion by 2028
• AIP Realty Trust Reports Q3 Financial Progress and Future Growth
• Weave Living and KKR Form Joint Venture to Enhance Japan's Housing Market
• Celsius Holdings Faces Legal Challenges—What Investors Should Know
• Lomiko Metals Secures Funding for La Loutre Graphite Project
• U.S. Gold Corp. Launches Significant $10.2 Million Offering
• Key Insights into the Growth of the Medical Nonwoven Market
• Exploring the Growth of the Portable Power Station Market
• Investors Alert: Class Action Update on Edwards Lifesciences
• Casio Unveils Iconic DW-5000R, A Nod to G-SHOCK Heritage
• Casio Unveils New DW-5000R, Reviving G-SHOCK's Legacy
• American Lithium's Annual Meeting Highlights and Future Plans
• Rentokil Initial PLC Faces Class Action Claims - Key Insights
• Significant Jury Victory for Guardant Health Against Natera
• Robbins LLP Highlights Class Action Opportunities for AILE Investors
• Legal Update: Dentsply Sirona Inc. Class Action Notification
• Exploring Growth within the Animal Feed Additives Industry
• Women’s Watch Market Set for Significant Growth by 2031
• Eisai and Biogen Launch LEQEMBI for Alzheimer's in New Markets
• Patterson Companies to Host Second Quarter Conference Call